長庚大學

經歷

2024~     長庚大學兼任部定副教授

2020~     林口長庚紀念醫院病理科副教授級主治醫師

2012~2024 長庚大學兼任部定助理教授

2011~2020 林口長庚紀念醫院病理科助理教授級主治醫師

2009~2012 長庚大學兼任部定講師

2008~2011 林口長庚紀念醫院病理科講師級主治醫師

2003~     林口長庚紀念醫院病理科主治醫師

2002~2003 林口長庚紀念醫院解剖病理科住院總醫師

1999~2002 林口長庚紀念醫院解剖病理科住院醫師

學會與認證

台灣病理學會

國際病理學會台灣分會

台灣臨床細胞學會

論文發表(近五年)

1. Lee YC, Lee LY, Huang Y, Kao HK, Chang YT, Hung SY, Lu CY, Chang YS, Yu JS, Chang KP. 2023 Oct. Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer. Laryngoscope Investig Otolaryngol. 2023;8(6):1547-1556 (SCI) (co-first author)

2.  Fan KH, Kang CJ, Lin CY, Ng SH, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Huang SF, Fang KH, Wang YC, Chang JT, Liao CT, Lee LY. 2023 Jan-Dec. Quantitative measurement of perineural invasion for prognosis analysis of oral cavity cancer treated by radical surgery with or without adjuvant therapy. Technol Cancer Res Treat. 2023;22:15330338231176366 (SCI) (corresponding author)

3.  Liao CT, Lee LY, Lee SR, Ng SH, Liu TW, Chien CY, Lin JC, Wang CP, Terng SD, Hua CH, Chen TM, Chen WC, Tsai YT, Kang CJ, Tsai CY, Chu YH, Lin CY, Fan KH, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Yen TC, Cheng NM, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Wen YW. 2022 Nov. Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals. Front Oncol. 2022;12:1019555 (SCI)

4.  Lee LY, Yang CH, Lin YC, Hsieh YH, Chen YA, Chang MD, Lin YY, Liao CT. 2022 Oct. A domain knowledge enhanced yield based deep learning classifier identifies perineural invasion in oral cavity squamous cell carcinoma. Front Oncol. 2022;12:951560 (SCI)

5.  Lin CY, Lee LY, Cheng NM, Lee SR, Tsai CY, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Kang CJ, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. 2021 Oct. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma. Cancer Med. 2021;10(20):6947-6958 (SCI) (co-first author)

6.  Lee LY, Lin CY, Cheng NM, Tsai CY, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Kang CJ, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. 2021 Oct. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines. Cancer Med. 2021;10(19):6627-6641 (SCI) (co-first author)

7.  Lee YC, Lee LY, Tsang NM, Hsu CL, Hsin LJ, Kuo TT, Chang KP. 2021 Mar. Prognostic significance of granuloma and amyloid deposition in nasopharyngeal carcinoma. Head Neck Pathol. 2021;15(1):153-162 (co-first author)

8.  Lin CY, Fan KH, Lee LY, Hsueh C, Yang LY, Ng SH, Wang HM, Hsieh CH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Lee LA, Huang SF, Chang KP, Yen TC, Tay ZY, Wen YW, Lee SR, Liao CT. 2020 Apr. Precision adjuvant therapy based on detailed pathological risk factors for resected oral cavity squamous cell carcinoma: long term outcome comparison of CGMH and NCCN guidelines.  Int J Radiat Oncol Biol Phys. 2020;106(5):916-925 (SCI) (co-first author)